Search
Close this search box.

Zhejiang Orient Gene Biotech sees highest patent filings and grants during October in Q4 2023

Zhejiang Orient Gene Biotech has been focused on protecting inventions in United States(US) with five publications in Q4 2023

The United States(US) Patent Office dominates the patent filings and grants with nearly 14% filings and 100% grants. The Australia(AU), China(CN), United States(US), and European Patent Office(EPO) patent Office are among the top ten patent offices where Zhejiang Orient Gene Biotech is filings its patents. Among the top granted patent authorities, Zhejiang Orient Gene Biotech has 100% of its grants in United States(US)

In terms of grant share, Zhejiang Orient Gene Biotech stands in ninth position among its competitors. and secured the top positions according to recent patent publication data.

Patents related to industrial automation and climate change lead Zhejiang Orient Gene Biotech’s portfolio

Zhejiang Orient Gene Biotech has the highest number of patents in industrial automation followed by, climate change and rare diseases. For industrial automation, nearly 57% of patents were filed and 100% of patents were granted in Q4 2023.

For comprehensive analysis of Zhejiang Orient Gene Biotech’s filings and grants, buy the databook here.

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.